rs1131690826
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_144997.7(FLCN):c.780G>A(p.Trp260*) variant causes a stop gained, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_144997.7 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLCN | ENST00000285071.9 | c.780G>A | p.Trp260* | stop_gained, splice_region_variant | Exon 8 of 14 | 1 | NM_144997.7 | ENSP00000285071.4 | ||
ENSG00000264187 | ENST00000427497.3 | n.149-2574G>A | intron_variant | Intron 4 of 11 | 1 | ENSP00000394249.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Birt-Hogg-Dube syndrome Pathogenic:2
Variant summary: FLCN c.780G>A (p.Trp260X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 243998 control chromosomes in gnonmAD. To our knowledge, no occurrence of c.780G>A in individuals affected with Birt-Hogg-Dube Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. A different nonsense variant, c.779G>A, resulting in the same premature stop codon, was previously reported in a Swiss family affected with Birt-Hogg-Dube Syndrome (Frolich_2008). The following publication has been ascertained in the context of this evaluation (PMID: 18579543). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp260*) in the FLCN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235). This nonsense change has been observed in individual(s) with Birt-Hogg-Dubé syndrome (PMID: 18579543, 22068306). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 428638). For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W260* pathogenic mutation (also known as c.780G>A), located in coding exon 5 of the FLCN gene, results from a G to A substitution at nucleotide position 780. This changes the amino acid from a tryptophan to a stop codon within coding exon 5. A different mutation, c.779G>A, resulting in the same premature stop codon, p.W260*, was previously reported in three members of a Swiss family affected with episodes of spontaneous pneumothorax and cystic lung cysts (Frolich BA et al. Eur Respir J. 2008 Nov;32(5):1316-20). This same alteration was identified in two brothers affected with head and neck fibrofolliculomas, lung cysts, spontaneous pneumothorax and lipoma of the kidney (Sattler EC et al Acta Derm Venereol. 2012 Mar;92(2)). In addition to the clinical data presented in the literature, since premature stop codons are typically deleterious in nature, this alteration is interpreted as a disease causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at